🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael C. Brumm

University of Iowa

ORCID: 0000-0002-3173-9989
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.3Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433
Top 12%
1.7DataRank
Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Papers

Driven by 13 papers — median percentile 75. Top paper: “Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression”.

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433
Top 12%
1.7DataRank
Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

npj Parkinson s Disease(2024)10.1038/s41531-024-00789-w
Top 25%
0.813DataRank
Top 25%37 citations

Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub +95 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

npj Parkinson s Disease(2022)10.1038/s41531-022-00404-w
Top 26%
0.783DataRank
Top 26%19 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +85 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1
N/A
0DataRank · unranked
1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2
N/A
0DataRank · unranked
42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699
N/A
0DataRank · unranked
76 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers: The PPMI cohort

Research Square(2022)10.21203/rs.3.rs-1719882/v1
N/A
0DataRank · unranked
3 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +11 more

Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000208033
N/A
0DataRank · unranked
23 citations

David J. Irwin, Thomas F. Tropea, Emma Rhodes, Jeffrey S. Phillips, Alice S. Chen-Plotkin +18 more

Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants

Journal of Parkinson s Disease(2024)10.3233/jpd-240015
N/A
0DataRank · unranked
18 citations

Samuel M. Goldman, Christopher S. Coffey, Andrew Siderowf, Tanya Simuni, Cheryl Meng +6 more

LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates

medRxiv(2024)10.1101/2024.07.22.24310806
N/A
0DataRank · unranked
4 citations

David-Erick Lafontant, Seung Ho Choi, Hirotaka Iwaki, Cornelis Blauwendraat, Andrew Singleton +20 more

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia

medRxiv(2024)10.1101/2024.12.12.24318917
N/A
0DataRank · unranked
0 citations

Anuprita R Nair, Ryan Kurth, Michael C. Brumm, Michele K. York, Roseanne D. Dobkin +20 more

Neuronal alpha-Synuclein Disease stage progression over five years

medRxiv(2024)10.1101/2024.12.17.24319172
Top 100%
0DataRank
Top 100%0 citations

Caroline Gochanour, Anuprita R Nair, Michael C. Brumm, Christopher S. Coffey, Kathleen L. Poston +14 more

Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example

Movement Disorders(2025)10.1002/mds.30111
N/A
0DataRank · unranked
8 citations

Michael C. Brumm, Ryan Kurth, Michele K. York, the Parkinson's Progression Markers Initiative, Daniel Weintraub